{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:58:36Z","timestamp":1790488716217,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006404.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000}}],"reference-count":83,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006404.pub3","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T05:19:32Z","timestamp":1547011172000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pyronaridine-artesunate for treating uncomplicated <i>Plasmodium falciparum<\/i>\n malaria"],"prefix":"10.1002","author":[{"given":"Joseph","family":"Pryce","sequence":"first","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hine","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"issue":"Suppl 6","key":"10.1002\/14651858.CD006404.pub3-BIB0002|cit1","first-page":"114","article-title":"Pyronaridine-artesunate versus artemether\/lumefantrine: efficacy in malaria patients with uncomplicated acute falciparum malaria: results of a pivotal Phase III trial","volume":"79","author":"Kayentao","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","article-title":"Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial","volume":"11","author":"Kayentao","year":"2012","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0003|cit3","unstructured":"NCT00541385 Pyronaridine\u00a0artesunate 3:1 granule formulation vs. Coartem\u00a9 crushed tablets in P.\u00a0falciparum\u00a0malaria pediatric patients www.clinicaltrials.gov\/show\/NCT00541385"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12916-015-0535-9","article-title":"Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia","volume":"13","author":"Nelwan","year":"2015","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0005|cit5","first-page":"51","article-title":"Efficacy of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis","volume":"81 Suppl","author":"Duparc","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0006|cit6","first-page":"101","article-title":"Safety of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis","volume":"81 Suppl","author":"Duparc","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","article-title":"Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial","volume":"6","author":"Poravuth","year":"2011","journal-title":"PLoS One"},{"issue":"8993","key":"10.1002\/14651858.CD006404.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(96)91558-5","article-title":"Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa","volume":"347","author":"Ringwald","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4269\/ajtmh.1999.61.446","article-title":"Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria","volume":"61","author":"Ringwald","year":"1999","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/513942","article-title":"Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children","volume":"26","author":"Ringwald","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12936-018-2340-3","article-title":"Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial","volume":"17","author":"Roth","year":"2018","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0012|cit12","unstructured":"NCT00403260 Pyronaridine\u00a0artesunate (3:1) versus mefloquine artesunate in P.\u00a0falciparum \u00a0malaria patients www.clinicaltrials.gov\/show\/NCT00403260"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0013|cit13","unstructured":"Rueangweerayut R Phyo AP Uchaisin C Poravuth Y Quang Binh T Tinto H A randomized clinical trial comparing the efficacy and safety of fixed-dose pyronaridine-artesunate versus mefloquine plus artesunate in uncomplicated Plasmodium falciparum malaria Submitted under review; personal communication by email from Isabelle Borghini Fuhrer, Medicines for Malaria Venture"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0014|cit14","first-page":"30","article-title":"Efficacy and safety of pyronaridine\/artesunate fixed-dose combination compared with mefloquine plus artesunate in patients with acute uncomplicated Plasmodium falciparum malaria: results of a pivotal phase III trial","volume":"14 Suppl 2","author":"Rueangweerayut","year":"2009","journal-title":"Tropical Medicine and International Health"},{"issue":"14","key":"10.1002\/14651858.CD006404.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Pyronaridine-artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD006404.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Supplement to: Pyronaridine-artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0017|cit17","unstructured":"Beshir KB Diallo N Fofana B Traore A Kodio A Togo A Measuring the efficacy of four ACT regimens in Mali using qPCR-based estimates of Plasmodium falciparum clearance time. 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, New Orleans (LA), 2013 Nov 02-06 American Journal of Tropical Medicine and Hygiene 2014"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006404.pub3-BIB0018|cit18","first-page":"94","article-title":"Randomized trial to assess the effect on qtc interval of repeated treatment of uncomplicated malaria with acts in Bobo-Dioulasso, Burkina Faso: relation between parasitemia and prolonged qtc","volume":"97","author":"Kabore","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","article-title":"Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial","volume":"16","author":"Sagara","year":"2016","journal-title":"Lancet Infectious Diseases"},{"issue":"10128","key":"10.1002\/14651858.CD006404.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","volume":"391","author":"Sagara","year":"2018","journal-title":"Lancet"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006404.pub3-BIB0021|cit21","first-page":"317","article-title":"Assessment of the dynamics of Plasmodium falciparum parasitemia regarding three artemisinin combination regimens for acute uncomplicated malaria treatment, Banfora, Burkina Faso","volume":"97","author":"Soulama","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0022|cit22","unstructured":"Soulama I Coulibaly AS Kabore MJ Ouattara M Bougouma EC Sanon S Safety and efficacy of repeated administration of pyronaridine-artesunate or dihydroartemisinin-piperaquine vs artesunate-amodiaquine in children and adult patients with acute uncomplicated Plasmodium sp malaria over of two years period at banfora\/niangoloko site in Burkina Faso. 65th annual meeting of the American Society of Tropical Medicine and Hygiene, Atlanta (GA), 2016 Nov 13-17 American Journal of Tropical Medicine and Hygiene 2017"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0023|cit23","unstructured":"Tekete M Djimde A Borrmann S A phase IIIb\/IV comparative, randomised, multi-centre, open label, parallel 3-arm clinical study to assess the safety and efficacy of repeated administration of four artemisinin-based combination therapy (ACT) over a two-year period in children and adult patients with acute uncomplicated Plasmodium sp. malaria 9. Jahrestreffen der AG Malaria der Sektion Antiparasitare Chemotherapie der Paul-Ehrlich-Gesellschaft fur Chemotherapie 2012"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0024|cit24","unstructured":"WANECAM trial authors Site data: Bobo, Burkina Faso (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0025|cit25","unstructured":"WANECAM trial authors Site data: Bougala, Mali (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0026|cit26","unstructured":"WANECAM trial authors Site data: Djoliba, Mali (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0027|cit27","unstructured":"WANECAM trial authors Site data: Kolle, Mali (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0028|cit28","unstructured":"WANECAM trial authors Site data: Mafrinyah, Guinea (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0029|cit29","unstructured":"WANECAM trial authors Site data: Ouaga, Burkina Faso (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0030|cit30","unstructured":"WANECAM trial authors Site data: Sotuba, Mali (as supplied 6 July 2017) Data on file"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0031|cit31","unstructured":"Shin CS Kwak YG Lee KD Borghini Fuhrer I Miller RM Duparc S Treatment of Korean vivax malaria patients with the fixed-dose combination of pyronaridine:artesunate 7th European Congress on Tropical Medicine and International Health 2011"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0032|cit32","first-page":"101","article-title":"Safety of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis","volume":"81 Suppl","author":"Duparc","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0033|cit33","first-page":"51","article-title":"Efficacy of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis","volume":"81 Suppl","author":"Duparc","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"9724","key":"10.1002\/14651858.CD006404.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","article-title":"Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial","volume":"375","author":"Tshefu","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub3-BIB0035|cit35","first-page":"285","article-title":"Effects of combined dose of pyronaridine\/sulfadoxine\/pyrimethamine on falciparum malaria","volume":"6","author":"Huang","year":"1988","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0036|cit36","first-page":"19","article-title":"Therapeutic effect of pyronaridine in plain tablets and enteric coated tablets in falciparum malaria patients","volume":"7","author":"Huang","year":"1989","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006404.pub3-BIB0037|cit37","first-page":"175","article-title":"Comparison of different regimen of pyronaridine and sulfadoxine combined with pyrimethamine in the treatment of malignant malaria","volume":"11","author":"Huang","year":"1993","journal-title":"Chinese Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD006404.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e1001773","DOI":"10.1371\/journal.pmed.1001773","article-title":"Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial","volume":"11","author":"Laman","year":"2014","journal-title":"PLoS Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006404.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AAC.00039-16","article-title":"Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in western Cambodia","volume":"60","author":"Leang","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1996.54.205","article-title":"Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD006404.pub3-BIB0041|cit41","first-page":"1004","article-title":"Results of a randomized, multicentre, phase II, dose-ranging, clinical study to assess the safety and efficacy of fixed dose, orally administered pyronaridine and artesunate in adult patients with acute uncomplicated Plasmodium falciparum malaria","volume":"77","author":"Looareesuwan","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub3-BIB0042|cit42","first-page":"855","article-title":"Pharmacokinetics, clinical and safety outcomes of pyronaridine\/artesunate treatment of acute Plasmodium falciparum malaria in Uganda","volume":"79","author":"Piola","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1086\/591096","article-title":"Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon","volume":"198","author":"Ramharter","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1475-2875-13-358","article-title":"Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali","volume":"13","author":"Sagara","year":"2014","journal-title":"Malaria Journal"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD006404.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/00034983.1992.11812693","article-title":"In vitro activity of pyronaridine against African strains of Plasmodium falciparum","volume":"86","author":"Basco","year":"1992","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1383-5769(99)00028-8","article-title":"Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro","volume":"48","author":"Chavalitshewinkoon-Petmitr","year":"2000","journal-title":"Parasitology International"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(92)90414-8","article-title":"Studies on a new antimalarial compound: pyronaridine","volume":"86","author":"Chang","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.1988.38.24","article-title":"In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum","volume":"38","author":"Childs","year":"1988","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0050|cit50","first-page":"270","article-title":"Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, et al","volume":"11","author":"Review of\u00a0pyronaridine\u00a0anti-malarial","year":"2012","journal-title":"Malaria Journal"},{"issue":"5","key":"10.1002\/14651858.CD006404.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"351","author":"Dondorp","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2875-12-70","article-title":"Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials","volume":"12","author":"Duparc","year":"2013","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0053|cit53","unstructured":"European Medicines Agency Summary of opinion: Pyramax (pyronaridine-artesunate) www.ema.europa.eu\/docs\/en_GB\/document_library\/Medicine_for_use_outside_EU\/2015\/11\/WC500196738.pdf"},{"issue":"11","key":"10.1002\/14651858.CD006404.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0169-4758(91)90267-R","article-title":"Pyronaridine: a new antimalarial drug","volume":"7","author":"Fu","year":"1991","journal-title":"Parasitology Today"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0055|cit55","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0056|cit56","unstructured":"Higgins JP Altman DG Sterne JA editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2875-8-79","article-title":"In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays","volume":"8","author":"Kurth","year":"2009","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0058|cit58","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"32","key":"10.1002\/14651858.CD006404.pub3-BIB0059|cit59","first-page":"1","article-title":"Systematic reviews of adverse effects: framework for a structured approach","volume":"7","author":"Loke","year":"2007","journal-title":"BMC Medical Research Methodology"},{"issue":"452","key":"10.1002\/14651858.CD006404.pub3-BIB0060|cit60","first-page":"1","article-title":"Artemisinin resistance-modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0061|cit61","unstructured":"MedDRA Medical Dictionary for Regulatory Activities 2016"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0062|cit62","unstructured":"TDR\/Medicines for Malaria Venture\/Shin Poong Pharmaceuticals Inc WHO TDR\/Medicines for Malaria Venture\/Shin Poong Pharmaceuticals Inc. sign agreement for development of pyronaridine-artesunate for treatment of malaria www.mmv.org\/newsroom\/press-releases\/tdrmedicines-malaria-ventureshin-poong-pharmaceuticals-inc-sign-agreement"},{"issue":"7","key":"10.1002\/14651858.CD006404.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.2012.11-0558","article-title":"Drug-drug interaction analysis of pyronaridine\/artesunate and ritonavir in healthy volunteers","volume":"86","author":"Morris","year":"2012","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0065|cit65","unstructured":"NCT03201770 Cohort event monitoring study of Pyramax clinicaltrials.gov\/ct2\/show\/NCT03201770"},{"issue":"24","key":"10.1002\/14651858.CD006404.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00034983.1997.11813123","article-title":"The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin","volume":"91","author":"Peters","year":"1997","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/42.3.333","article-title":"In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents","volume":"42","author":"Pradines","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD006404.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/AAC.00801-10","article-title":"In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax","volume":"54","author":"Price","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0070|cit70","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/AAC.43.6.1525","article-title":"In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum","volume":"43","author":"Ringwald","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0072|cit72","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) GRADE handbook for grading quality of evidence and strength of recommendations gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007483.pub2","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","author":"Sinclair","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actatropica.2007.12.005","article-title":"Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo","volume":"105","author":"Vivas","year":"2008","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0075|cit75","unstructured":"World Health Organization Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. December 2003 www.who.int\/malaria\/publications\/atoz\/whohtmrbm200350\/en\/"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0076|cit76","unstructured":"World Health Organization WHO guidelines for the treatment of malaria. 2006 http:\/\/archives.who.int\/publications\/2006\/9241546948_eng.pdf"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0077|cit77","unstructured":"World Health Organization Methods for surveillance of antimalarial drug efficacy. November 2009 www.who.int\/malaria\/publications\/atoz\/9789241597531\/en\/"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0078|cit78","unstructured":"World Health Organization Global plan for artemisinin resistance containment (GPARC) www.who.int\/malaria\/publications\/atoz\/9789241500838\/en\/index.html"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0079|cit79","unstructured":"World Health Organization Guidelines for the treatment of malaria - 3rd edition. April 2015 www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/"},{"key":"10.1002\/14651858.CD006404.pub3-BIB0080|cit80","unstructured":"World Health Organization World Malaria Report 2017 www.who.int\/malaria\/publications\/world-malaria-report-2017\/en\/"},{"issue":"157","key":"10.1002\/14651858.CD006404.pub3-BIB0081|cit81","first-page":"1","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006404.pub2","article-title":"Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria","author":"Bukirwa","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub3-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006404","article-title":"Pyronaridine for treating uncomplicated malaria","author":"Unnikrishnan","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006404.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006404.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:58:56Z","timestamp":1628546336000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006404.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":83,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006404.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006404.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]}}}